Real-time enrollment status for this graves disease clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 6:16 PM UTC
| NCT Number | NCT06980649 |
| Recruiting Status | Recruiting |
| Condition | Graves Disease |
| Phase | PHASE1 |
| Target Enrollment | 15 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Biohaven Therapeutics Ltd. |
| Last Updated on CT.gov | July 31, 2026 (3 weeks ago) |
As of August 27, 2026: Clinical trial NCT06980649 is currently recruiting participants. This phase1 study for graves disease is actively seeking new participants at 10 locations across the United States. The study is sponsored by Biohaven Therapeutics Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06980649 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06980649 was last updated 3 weeks ago (July 31, 2026). HelloStudys verifies this status automatically.